Price target
42.800.000.00%
The 5 analysts offering 1 year price forecasts for 0LB2 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to 0LB2 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0LB2 EPS for the last quarter is 1.17 USD despite the estimation of 0.44 USD. In the next quarter EPS is expected to reach 0.50 USD. Track more of SUPERNUS PHARMACEUTICALS INC USD0.001 financials and stay on top of what is up with the company.
In the next quarter SUPERNUS PHARMACEUTICALS INC USD0.001 revenue is expected to reach 154.25 M USD. Check out SUPERNUS PHARMACEUTICALS INC USD0.001 revenue and earnings and make informed decisions.
According to analysts, 0LB2 price target is 42.80 USD with a max estimate of 57.00 USD and a min estimate of 36.00 USD. Check if this forecast comes true in a year, meanwhile watch SUPERNUS PHARMACEUTICALS INC USD0.001 stock price chart and keep track of the current situation with 0LB2 news and stock market news.
We've gathered opinions of 5 analysts rating 0LB2 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.